Part II | Vascular risk factors for depression and apathy 141 7 77. Robert G, Bannier E, Comte M, et al. Multimodal brain imaging connectivity analyses of emotional and motivational deficits in depression among women. J Psychiatry Neurosci. 2021;46(2):E303-E312. doi:10.1503/ JPN.200074 78. Ruthirakuhan M, Herrmann N, Vieira D, Gallagher D, Lanctôt KL. The Roles of Apathy and Depression in Predicting Alzheimer Disease: A Longitudinal Analysis in Older Adults With Mild Cognitive Impairment. Am J Geriatr Psychiatry. 2019;27(8):873-882. doi:10.1016/J. JAGP.2019.02.003 79. Bakker TJEM, Duivenvoorden HJ, Van Der Lee J, Trijsburg RW. Prevalence of psychiatric function disorders in psychogeriatric patients at referral to nursing home care--the relation to cognition, activities of daily living and general details. Dement Geriatr Cogn Disord. 2005;20(4):215-224. doi:10.1159/000087298 80. Rosenberg GA, Wallin A, Wardlaw JM, et al. Consensus statement for diagnosis of subcortical small vessel disease. J Cereb Blood Flow Metab. 2016;36(1):6-25. doi:10.1038/jcbfm.2015.172 81. Gupta D, Kuruvilla A. Vascular parkinsonism: what makes it different? Postgrad Med J. 2011;87(1034):829-836. doi:10.1136/ POSTGRADMEDJ-2011-130051 82. Graham NL, Emery T, Hodges JR. Distinctive cognitive profiles in Alzheimer’s disease and subcortical vascular dementia. J Neurol Neurosurg Psychiatry. 2004;75(1):61-71. doi:10.1016/s00843970(08)70286-x 83. Marin RS, Firinciogullari S, Biedrzycki RC. The sources of convergence between measures of apathy and depression. J Affect Disord. 1993;28(2):117-124. doi:10.1016/0165-0327(93)90040-Q 84. Bertens AS, Foster-Dingley JC, van der Grond J, Moonen JEF, van der Mast RC, Rius Ottenheim N. Lower Blood Pressure, Small-Vessel Disease, and Apathy in Older Persons With Mild Cognitive Deficits. J Am Geriatr Soc. 2020;68(8):1811-1817. doi:10.1111/JGS.16465 85. Manera V, Abrahams S, Ag L, et al. Recommendations for the Nonpharmacological Treatment of Apathy in Brain Disorders A R T I C L E I N F O. Am J Geriatr Psychiatry. 2020;28:410-420. doi:10.1016/j.jagp.2019.07.014 86. Ruthirakuhan MT, Herrmann N, Abraham EH, Chan S, Lanctôt KL. Pharmacological interventions for apathy in Alzheimer’s disease. Cochrane database Syst Rev. 2018;5(5). doi:10.1002/14651858. CD012197.PUB2 87. Seppi K, Ray Chaudhuri K, Coelho M, et al. Update on treatments for nonmotor symptoms of Parkinson’s disease-an evidence-based medicine review. Mov Disord. 2019;34(2):180-198. doi:10.1002/ MDS.27602 88. Ward A. Causal criteria and the problem of complex causation. Med Heal Care Philos. 2009;12(3):333-343. doi:10.1007/ s11019-009-9182-2
RkJQdWJsaXNoZXIy MjY0ODMw